A new report reveals the heavy personal and economic toll of MS and recommends more complete, patient focused approaches to ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

Patients with hidradenitis suppurativa (HS) who started on or switched to biosimilar adalimumab experienced lower treatment success and lost response more quickly, according to an Australian study ...

Beginning Jan. 1, 2026, Optum Rx, the pharmacy benefit manager of UnitedHealthcare, will reduce reauthorizations for an ...

The investigators found that one laboratory value—elevated erythrocyte sedimentation rate (ESR)—was also tied with longer ...

The FDA has approved a new type of medication to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS), ...

ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...

A new study suggests epigenetic changes at Type 1 diabetes susceptibility genes may explain the risk profile of children born ...

Telehealth replaces 74% of office visits, according to the operational analysis of telehealth utilization from 2019 to 2023, ...

Kamuvudines are a new class of drugs that are derived from the anti-HIV nucleoside reverse transcriptase inhibitors. They are designed to inhibit the inflammasome, part of the innate immune system ...

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...

Public health experts warn that a major communication failure could worsen mistrust of vaccines, a problem brought to light ...